Skip to main content
Top
Published in: International Journal of Clinical Oncology 4/2024

06-02-2024 | Original Article

Hydronephrosis severity as a predictor of postoperative renal function decline following laparoscopic radical nephroureterectomy

Authors: Toru Kanno, Go Kobori, Ryoichi Saito, Katsuhiro Ito, Hiromichi Nakagawa, Toshifumi Takahashi, Shigeki Koterazawa, Naoto Takaoka, Shinya Somiya, Takao Haitani, Kanji Nagahama, Masaaki Ito, Yoshihito Higashi, Seiji Moroi, Toshiya Akao, Hitoshi Yamada

Published in: International Journal of Clinical Oncology | Issue 4/2024

Login to get access

Abstract

Background

This study aimed to investigate factors, including the degree of hydronephrosis, that may be associated with decreased renal function after radical nephroureterectomy (RNU).

Methods

This study included 252 patients who underwent laparoscopic RNU with an estimated glomerular filtration rate (eGFR) ≥ 30 ml/min/1.73 m2 in three institutions. We assessed the association between hydronephrosis grade and perioperative renal function and performed a stepwise multivariate linear regression analysis to identify factors associated with postoperative eGFR. Patients with preoperative eGFR ≥ 50 ml/min/1.73 m2 were divided into a training set and an independent external validation set to develop a predictive model for postoperative renal function.

Results

The median preoperative and postoperative eGFR were 61.1 and 46.4 ml/min/1.73 m2, respectively. The eGFR preservation rates were 66.9%, 66.6%, 88.1%, and 100.0% in groups without, with mild, moderate, and severe hydronephrosis, respectively, and this difference was statistically significant (p < 0.001). Multivariate analysis revealed that factors predictive of postoperative eGFR included sex, preoperative eGFR, clinical T stage (cT3–4), and the presence of moderate or severe hydronephrosis. Our predictive model, based on these factors, positively correlated with actual postoperative renal function, and the similarity in categories with or without renal function insufficiency between predicted and actual postoperative renal functions was 78% in both training and validation sets.

Conclusion

Moderate or severe hydronephrosis is associated with a modest postoperative decline in renal function, while mild hydronephrosis is not. Our predictive model may be useful in predicting postoperative renal function insufficiency and guiding decision-making for perioperative medical treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rouprêt M, Seisen T, Birtle AJ et al (2023) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol 84(1):49–64CrossRefPubMed Rouprêt M, Seisen T, Birtle AJ et al (2023) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol 84(1):49–64CrossRefPubMed
2.
go back to reference Birtle A, Johnson M, Chester J et al (2020) Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet 395(10232):1268–1277CrossRefPubMedPubMedCentral Birtle A, Johnson M, Chester J et al (2020) Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet 395(10232):1268–1277CrossRefPubMedPubMedCentral
3.
go back to reference Pinar U, Calleris G, Grobet-Jeandin E et al (2023) The role of perioperative chemotherapy for upper tract urothelial carcinoma patients treated with radical nephroureterectomy. World J Urol 41(11):3205–3230CrossRefPubMed Pinar U, Calleris G, Grobet-Jeandin E et al (2023) The role of perioperative chemotherapy for upper tract urothelial carcinoma patients treated with radical nephroureterectomy. World J Urol 41(11):3205–3230CrossRefPubMed
4.
go back to reference Wu Z, Chen Q, Djaladat H et al (2021) A preoperative nomogram to predict renal function insufficiency for cisplatin-based adjuvant chemotherapy following minimally invasive radical nephroureterectomy (ROBUUST collaborative group). Eur Urol Focus 8(1):173–181CrossRefPubMed Wu Z, Chen Q, Djaladat H et al (2021) A preoperative nomogram to predict renal function insufficiency for cisplatin-based adjuvant chemotherapy following minimally invasive radical nephroureterectomy (ROBUUST collaborative group). Eur Urol Focus 8(1):173–181CrossRefPubMed
5.
go back to reference Tian Y, Gong Y, Pang Y et al (2016) Clinical and prognostic value of preoperative hydronephrosis in upper tract urothelial carcinoma: a systematic review and meta-analysis. PeerJ 4:e2144CrossRefPubMedPubMedCentral Tian Y, Gong Y, Pang Y et al (2016) Clinical and prognostic value of preoperative hydronephrosis in upper tract urothelial carcinoma: a systematic review and meta-analysis. PeerJ 4:e2144CrossRefPubMedPubMedCentral
6.
go back to reference Chung PH, Krabbe LM, Darwish OM et al (2014) Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract. Urol Oncol 32(7):981–988CrossRefPubMed Chung PH, Krabbe LM, Darwish OM et al (2014) Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract. Urol Oncol 32(7):981–988CrossRefPubMed
7.
go back to reference Kanno T, Kobori G, Ito K et al (2022) Oncological outcomes of retroperitoneal lymph node dissection during retroperitoneal laparoscopic radical nephroureterectomy for renal pelvic or upper ureteral tumors: matched-pair analysis. J Endourol 36(9):1206–1213CrossRefPubMed Kanno T, Kobori G, Ito K et al (2022) Oncological outcomes of retroperitoneal lymph node dissection during retroperitoneal laparoscopic radical nephroureterectomy for renal pelvic or upper ureteral tumors: matched-pair analysis. J Endourol 36(9):1206–1213CrossRefPubMed
8.
go back to reference Kanno T, Kobori G, Ito K et al (2022) Complications and their management following retroperitoneal lymph node dissection in conjunction with retroperitoneal laparoscopic radical nephroureterectomy. Int J Urol 29(5):455–461CrossRefPubMed Kanno T, Kobori G, Ito K et al (2022) Complications and their management following retroperitoneal lymph node dissection in conjunction with retroperitoneal laparoscopic radical nephroureterectomy. Int J Urol 29(5):455–461CrossRefPubMed
9.
go back to reference Koterazawa S, Somiya S, Ito K et al (2023) The efficacy of ultrasonography for the detection of upper tract urothelial carcinoma. J Med Ultrason (2001) 50(2):197–203CrossRefPubMed Koterazawa S, Somiya S, Ito K et al (2023) The efficacy of ultrasonography for the detection of upper tract urothelial carcinoma. J Med Ultrason (2001) 50(2):197–203CrossRefPubMed
10.
go back to reference Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. modification of diet in renal disease study group. Ann Intern Med 130(6):461–470CrossRefPubMed Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. modification of diet in renal disease study group. Ann Intern Med 130(6):461–470CrossRefPubMed
11.
go back to reference Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48(3):452–458CrossRefPubMed Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48(3):452–458CrossRefPubMed
12.
go back to reference Meyer JP, Delves GH, Sullivan ME et al (2006) The effect of nephroureterectomy on glomerular filtration rate. BJU Int 98(4):845–848CrossRefPubMed Meyer JP, Delves GH, Sullivan ME et al (2006) The effect of nephroureterectomy on glomerular filtration rate. BJU Int 98(4):845–848CrossRefPubMed
13.
go back to reference Kaag MG, O’Malley RL, O’Malley P et al (2010) Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol 58(4):581–587CrossRefPubMedPubMedCentral Kaag MG, O’Malley RL, O’Malley P et al (2010) Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol 58(4):581–587CrossRefPubMedPubMedCentral
14.
go back to reference Lane BR, Smith AK, Larson BT et al (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 116(12):2967–2973CrossRefPubMed Lane BR, Smith AK, Larson BT et al (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 116(12):2967–2973CrossRefPubMed
15.
go back to reference Hoshino K, Kikuchi E, Tanaka N et al (2012) Preoperative hydronephrosis: independent predictor for changes in renal function following nephroureterectomy. Jpn J Clin Oncol 42(3):202–207CrossRefPubMed Hoshino K, Kikuchi E, Tanaka N et al (2012) Preoperative hydronephrosis: independent predictor for changes in renal function following nephroureterectomy. Jpn J Clin Oncol 42(3):202–207CrossRefPubMed
16.
go back to reference Xylinas E, Rink M, Margulis V et al (2013) Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int 112(4):453–461CrossRefPubMed Xylinas E, Rink M, Margulis V et al (2013) Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int 112(4):453–461CrossRefPubMed
17.
go back to reference Kaag M, Trost L, Thompson RH et al (2014) Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma. BJU Int 114(5):674–679CrossRefPubMed Kaag M, Trost L, Thompson RH et al (2014) Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma. BJU Int 114(5):674–679CrossRefPubMed
18.
go back to reference Shao IH, Lin YH, Hou CP et al (2014) Risk factors associated with ineligibility of adjuvant cisplatin-based chemotherapy after nephroureterectomy. Drug Des Devel Ther 8:1985–1990PubMedPubMedCentral Shao IH, Lin YH, Hou CP et al (2014) Risk factors associated with ineligibility of adjuvant cisplatin-based chemotherapy after nephroureterectomy. Drug Des Devel Ther 8:1985–1990PubMedPubMedCentral
19.
go back to reference Hashimoto T, Ohno Y, Nakashima J et al (2015) Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma. Jpn J Clin Oncol 45(11):1064–1068CrossRefPubMed Hashimoto T, Ohno Y, Nakashima J et al (2015) Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma. Jpn J Clin Oncol 45(11):1064–1068CrossRefPubMed
20.
go back to reference Singla N, Hutchinson R, Menegaz C et al (2016) Comparing changes in renal function after radical surgery for upper tract urothelial carcinoma and renal cell carcinoma. Urology 96:44–53CrossRefPubMed Singla N, Hutchinson R, Menegaz C et al (2016) Comparing changes in renal function after radical surgery for upper tract urothelial carcinoma and renal cell carcinoma. Urology 96:44–53CrossRefPubMed
21.
go back to reference Tafuri A, Marchioni M, Cerrato C et al (2022) Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (radical nephroureterectomy outcomes (RaNeO) research consortium). World J Urol 40(11):2771–2779CrossRefPubMedPubMedCentral Tafuri A, Marchioni M, Cerrato C et al (2022) Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (radical nephroureterectomy outcomes (RaNeO) research consortium). World J Urol 40(11):2771–2779CrossRefPubMedPubMedCentral
22.
go back to reference Cheng PY, Lee HY, Li WM et al (2023) Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma. Front Oncol 13:944321CrossRefPubMedPubMedCentral Cheng PY, Lee HY, Li WM et al (2023) Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma. Front Oncol 13:944321CrossRefPubMedPubMedCentral
23.
go back to reference Okuyama Y, Hatakeyama S, Tabata R et al (2023) Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: a multicenter retrospective study. Int J Urol 30(8):649–657CrossRefPubMed Okuyama Y, Hatakeyama S, Tabata R et al (2023) Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: a multicenter retrospective study. Int J Urol 30(8):649–657CrossRefPubMed
Metadata
Title
Hydronephrosis severity as a predictor of postoperative renal function decline following laparoscopic radical nephroureterectomy
Authors
Toru Kanno
Go Kobori
Ryoichi Saito
Katsuhiro Ito
Hiromichi Nakagawa
Toshifumi Takahashi
Shigeki Koterazawa
Naoto Takaoka
Shinya Somiya
Takao Haitani
Kanji Nagahama
Masaaki Ito
Yoshihito Higashi
Seiji Moroi
Toshiya Akao
Hitoshi Yamada
Publication date
06-02-2024
Publisher
Springer Nature Singapore
Published in
International Journal of Clinical Oncology / Issue 4/2024
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-024-02468-5

Other articles of this Issue 4/2024

International Journal of Clinical Oncology 4/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine